These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11883454)

  • 21. Institutional review boards (IRBs) and regulations on research with elders.
    Maloney DM
    Hum Res Rep; 2002 Nov; 17(11):9. PubMed ID: 12708415
    [No Abstract]   [Full Text] [Related]  

  • 22. IRB policies regarding finder's fees and role conflicts in recruiting research participants.
    Wolf LE
    IRB; 2009; 31(1):14-9. PubMed ID: 19241735
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 24. Guiding IRBs and educating researchers.
    Wood J
    Am J Bioeth; 2003; 3(4):W4. PubMed ID: 14744303
    [No Abstract]   [Full Text] [Related]  

  • 25. How institutional review boards (IRBs) can handle adverse event reports.
    Maloney DM
    Hum Res Rep; 2006 Jan; 21(1):1-3. PubMed ID: 16789305
    [No Abstract]   [Full Text] [Related]  

  • 26. IRBs and monitoring the safety of clinical trials.
    Maloney DM
    Hum Res Rep; 2003 Jan; 18(1):3. PubMed ID: 12755095
    [No Abstract]   [Full Text] [Related]  

  • 27. Going beyond parents and institutional review boards in protecting children involved in nontherapeutic research.
    Rubinstein E
    Gold Gate Univ Law Rev; 2003; 33(2):251-94. PubMed ID: 15164740
    [No Abstract]   [Full Text] [Related]  

  • 28. Financial conflicts of interest and protection of human research subjects.
    Maloney DM
    Hum Res Rep; 2004 Jun; 19(6):1-2. PubMed ID: 15462034
    [No Abstract]   [Full Text] [Related]  

  • 29. IRBs and public use data files.
    Maloney DM
    Hum Res Rep; 2002 Aug; 17(8):4. PubMed ID: 12731494
    [No Abstract]   [Full Text] [Related]  

  • 30. HIPAA and what institutional review boards (IRBs) do not have to review.
    Maloney DM
    Hum Res Rep; 2003 Dec; 18(12):1-2. PubMed ID: 15027429
    [No Abstract]   [Full Text] [Related]  

  • 31. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.
    Jordan KA
    Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696
    [No Abstract]   [Full Text] [Related]  

  • 32. New privacy rule has more tasks for IRBs.
    Maloney DM
    Hum Res Rep; 2001 Feb; 16(2):4. PubMed ID: 12530379
    [No Abstract]   [Full Text] [Related]  

  • 33. Debate: should Australia move towards a centralized ethics committees system? The case for.
    Fox RM
    Intern Med J; 2005 Apr; 35(4):247-8. PubMed ID: 15836504
    [No Abstract]   [Full Text] [Related]  

  • 34. IRBs, human subjects, and reporting adverse events.
    Maloney DM
    Hum Res Rep; 2005 Nov; 20(11):3. PubMed ID: 16358480
    [No Abstract]   [Full Text] [Related]  

  • 35. Roles and actions of IRBs as it relates to the process of drug and device development.
    Silverstein JH; Bienstock C
    Mt Sinai J Med; 2008; 75(1):59-62. PubMed ID: 18306252
    [No Abstract]   [Full Text] [Related]  

  • 36. IRBs, data sharing, and privacy of human subjects.
    Maloney DM
    Hum Res Rep; 2002 Apr; 17(4):3. PubMed ID: 12374179
    [No Abstract]   [Full Text] [Related]  

  • 37. SACHRP recommendations for review of children's research requiring DHHS secretary's approval.
    Fisher CB; Kornetsky SZ
    IRB; 2005; 27(3):8-10. PubMed ID: 16021795
    [No Abstract]   [Full Text] [Related]  

  • 38. Research, regulations, and responsibility: confronting the compliance myth--a reaction to Professor Gatter.
    Koski G
    Emory Law J; 2003; 52(1):403-16. PubMed ID: 15575097
    [No Abstract]   [Full Text] [Related]  

  • 39. Protection of health research participants in the United States: a review of two cases.
    Douglass A; Crampton P
    N Z Bioeth J; 2004 Jun; 5(2):6-12. PubMed ID: 15597497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New requirements for vulnerable subjects and IRB membership.
    Maloney DM
    Hum Res Rep; 2000 Oct; 15(10):9. PubMed ID: 11917935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.